1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Duchenne Muscular Dystrophy Consumption 2016-2026 2.1.2 Duchenne Muscular Dystrophy Consumption CAGR by Region 2.2 Duchenne Muscular Dystrophy Segment by Type 2.2.1 Exondys 51 2.2.2 Emflaza 2.2.3 Translarna 2.3 Duchenne Muscular Dystrophy Sales by Type 2.3.1 Global Duchenne Muscular Dystrophy Sales Market Share by Type (2016-2021) 2.3.2 Global Duchenne Muscular Dystrophy Revenue and Market Share by Type (2016-2021) 2.3.3 Global Duchenne Muscular Dystrophy Sale Price by Type (2016-2021) 2.4 Duchenne Muscular Dystrophy Segment by Application 2.4.1 Hospitals 2.4.2 Clinics 2.4.3 Home Care 2.5 Duchenne Muscular Dystrophy Sales by Application 2.5.1 Global Duchenne Muscular Dystrophy Sale Market Share by Application (2016-2021) 2.5.2 Global Duchenne Muscular Dystrophy Revenue and Market Share by Application (2016-2021) 2.5.3 Global Duchenne Muscular Dystrophy Sale Price by Application (2016-2021) 3 Global Duchenne Muscular Dystrophy by Company 3.1 Global Duchenne Muscular Dystrophy Sales Market Share by Company 3.1.1 Global Duchenne Muscular Dystrophy Sales by Company (2019-2021) 3.1.2 Global Duchenne Muscular Dystrophy Sales Market Share by Company (2019-2021) 3.2 Global Duchenne Muscular Dystrophy Revenue Market Share by Company 3.2.1 Global Duchenne Muscular Dystrophy Revenue by Company (2019-2021) 3.2.2 Global Duchenne Muscular Dystrophy Revenue Market Share by Company (2019-2021) 3.3 Global Duchenne Muscular Dystrophy Sale Price by Company 3.4 Global Manufacturers Duchenne Muscular Dystrophy Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Duchenne Muscular Dystrophy Product Location Distribution 3.4.2 Players Duchenne Muscular Dystrophy Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 Duchenne Muscular Dystrophy by Region 4.1 Global Duchenne Muscular Dystrophy by Region 4.1.1 Global Duchenne Muscular Dystrophy Sales by Region 4.1.2 Global Duchenne Muscular Dystrophy Revenue by Region 4.2 Americas Duchenne Muscular Dystrophy Sales Growth 4.3 APAC Duchenne Muscular Dystrophy Sales Growth 4.4 Europe Duchenne Muscular Dystrophy Sales Growth 4.5 Middle East & Africa Duchenne Muscular Dystrophy Sales Growth 5 Americas 5.1 Americas Duchenne Muscular Dystrophy Sales by Country 5.1.1 Americas Duchenne Muscular Dystrophy Sales by Country (2016-2021) 5.1.2 Americas Duchenne Muscular Dystrophy Revenue by Country (2016-2021) 5.2 Americas Duchenne Muscular Dystrophy Sales by Type 5.3 Americas Duchenne Muscular Dystrophy Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Duchenne Muscular Dystrophy Sales by Region 6.1.1 APAC Duchenne Muscular Dystrophy Sales by Region (2016-2021) 6.1.2 APAC Duchenne Muscular Dystrophy Revenue by Region (2016-2021) 6.2 APAC Duchenne Muscular Dystrophy Sales by Type 6.3 APAC Duchenne Muscular Dystrophy Sales by Application 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Duchenne Muscular Dystrophy by Country 7.1.1 Europe Duchenne Muscular Dystrophy Sales by Country (2016-2021) 7.1.2 Europe Duchenne Muscular Dystrophy Revenue by Country (2016-2021) 7.2 Europe Duchenne Muscular Dystrophy Sales by Type 7.3 Europe Duchenne Muscular Dystrophy Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Duchenne Muscular Dystrophy by Country 8.1.1 Middle East & Africa Duchenne Muscular Dystrophy Sales by Country (2016-2021) 8.1.2 Middle East & Africa Duchenne Muscular Dystrophy Revenue by Country (2016-2021) 8.2 Middle East & Africa Duchenne Muscular Dystrophy Sales by Type 8.3 Middle East & Africa Duchenne Muscular Dystrophy Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Country 9 Market Drivers, Challenges and Trends 9.1 Market Drivers and Impact 9.1.1 Growing Demand from Key Regions 9.1.2 Growing Demand from Key Applications and Potential Industries 9.2 Market Challenges and Impact 9.3 Market Trends 10 Marketing, Distributors and Customer 10.1 Sales Channel 10.1.1 Direct Channels 10.1.2 Indirect Channels 10.2 Duchenne Muscular Dystrophy Distributors 10.3 Duchenne Muscular Dystrophy Customer 11 Global Duchenne Muscular Dystrophy Market Forecast 11.1 Global Duchenne Muscular Dystrophy Forecast by Region 11.1.1 Global Duchenne Muscular Dystrophy Forecast by Regions (2021-2026) 11.2.2 Global Duchenne Muscular Dystrophy Revenue Forecast by Regions (2021-2026) 11.2 Americas Forecast by Country 11.3 APAC Forecast by Region 11.4 Europe Forecast by Country 11.5 Middle East & Africa Forecast by Country 11.6 Global Duchenne Muscular Dystrophy Forecast by Type 11.7 Global Duchenne Muscular Dystrophy Forecast by Application 12 Key Players Analysis 12.1 Sarepta Therapeutics 12.1.1 Sarepta Therapeutics Company Information 12.1.2 Sarepta Therapeutics Duchenne Muscular Dystrophy Product Offered 12.1.3 Sarepta Therapeutics Duchenne Muscular Dystrophy Sales, Revenue, Price and Gross Margin (2019-2021) 12.1.4 Sarepta Therapeutics Main Business Overview 12.1.5 Sarepta Therapeutics Latest Developments 12.2 PTC Therapeutics 12.2.1 PTC Therapeutics Company Information 12.2.2 PTC Therapeutics Duchenne Muscular Dystrophy Product Offered 12.2.3 PTC Therapeutics Duchenne Muscular Dystrophy Sales, Revenue, Price and Gross Margin (2019-2021) 12.2.4 PTC Therapeutics Main Business Overview 12.2.5 PTC Therapeutics Latest Developments 12.3 Pfizer 12.3.1 Pfizer Company Information 12.3.2 Pfizer Duchenne Muscular Dystrophy Product Offered 12.3.3 Pfizer Duchenne Muscular Dystrophy Sales, Revenue, Price and Gross Margin (2019-2021) 12.3.4 Pfizer Main Business Overview 12.3.5 Pfizer Latest Developments 12.4 Bristol-Myers Squibb 12.4.1 Bristol-Myers Squibb Company Information 12.4.2 Bristol-Myers Squibb Duchenne Muscular Dystrophy Product Offered 12.4.3 Bristol-Myers Squibb Duchenne Muscular Dystrophy Sales, Revenue, Price and Gross Margin (2019-2021) 12.4.4 Bristol-Myers Squibb Main Business Overview 12.4.5 Bristol-Myers Squibb Latest Developments 12.5 Italfarmaco 12.5.1 Italfarmaco Company Information 12.5.2 Italfarmaco Duchenne Muscular Dystrophy Product Offered 12.5.3 Italfarmaco Duchenne Muscular Dystrophy Sales, Revenue, Price and Gross Margin (2019-2021) 12.5.4 Italfarmaco Main Business Overview 12.5.5 Italfarmaco Latest Developments 12.6 Santhera Pharmaceuticals 12.6.1 Santhera Pharmaceuticals Company Information 12.6.2 Santhera Pharmaceuticals Duchenne Muscular Dystrophy Product Offered 12.6.3 Santhera Pharmaceuticals Duchenne Muscular Dystrophy Sales, Revenue, Price and Gross Margin (2019-2021) 12.6.4 Santhera Pharmaceuticals Main Business Overview 12.6.5 Santhera Pharmaceuticals Latest Developments ... 13 Research Findings and Conclusion

List of Tables Table 1. Duchenne Muscular Dystrophy Consumption CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Exondys 51 Table 3. Major Players of Emflaza Table 4. Major Players of Translarna Table 5. Global Duchenne Muscular Dystrophy Sales by Type (2016-2021) & (K Doses) Table 6. Global Duchenne Muscular Dystrophy Sales Market Share by Type (2016-2021) Table 7. Global Duchenne Muscular Dystrophy Revenue by Type (2016-2021) & ($ million) Table 8. Global Duchenne Muscular Dystrophy Revenue Market Share by Type (2016-2021) Table 9. Global Duchenne Muscular Dystrophy Sale Price by Type (2016-2021) Table 10. Global Duchenne Muscular Dystrophy Sales by Application (2016-2021) & (K Doses) Table 11. Global Duchenne Muscular Dystrophy Sales Market Share by Application (2016-2021) Table 12. Global Duchenne Muscular Dystrophy Value by Application (2016-2021) Table 13. Global Duchenne Muscular Dystrophy Revenue Market Share by Application (2016-2021) Table 14. Global Duchenne Muscular Dystrophy Sale Price by Application (2016-2021) Table 15. Global Duchenne Muscular Dystrophy Sales by Company (2019-2021) & (K Doses) Table 16. Global Duchenne Muscular Dystrophy Sales Market Share by Company (2019-2021) Table 17. Global Duchenne Muscular Dystrophy Revenue by Company (2019-2021) ($ Millions) Table 18. Global Duchenne Muscular Dystrophy Revenue Market Share by Company (2019-2021) Table 19. Global Duchenne Muscular Dystrophy Sale Price by Company (2019-2021) Table 20. Key Manufacturers Duchenne Muscular Dystrophy Producing Area Distribution and Sales Area Table 21. Players Duchenne Muscular Dystrophy Products Offered Table 22. Duchenne Muscular Dystrophy Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) Table 23. New Products and Potential Entrants Table 24. Mergers & Acquisitions, Expansion Table 25. Global Duchenne Muscular Dystrophy Sales by Region (2016-2021) (K Doses) Table 26. Global Duchenne Muscular Dystrophy Sales Market Share by Region (2016-2021) Table 27. Global Duchenne Muscular Dystrophy Revenue by Region (2016-2021) & ($ Millions) Table 28. Global Duchenne Muscular Dystrophy Revenue Market Share by Region (2016-2021) Table 29. Americas Duchenne Muscular Dystrophy Sales by Country (2016-2021) & (K Doses) Table 30. Americas Duchenne Muscular Dystrophy Sales Market Share by Country (2016-2021) Table 31. Americas Duchenne Muscular Dystrophy Revenue by Country (2016-2021) & ($ Millions) Table 32. Americas Duchenne Muscular Dystrophy Revenue Market Share by Country (2016-2021) Table 33. Americas Duchenne Muscular Dystrophy Sales by Type (2016-2021) & (K Doses) Table 34. Americas Duchenne Muscular Dystrophy Sales Market Share by Type (2016-2021) Table 35. Americas Duchenne Muscular Dystrophy Sales by Application (2016-2021) & (K Doses) Table 36. Americas Duchenne Muscular Dystrophy Sales Market Share by Application (2016-2021) Table 37. APAC Duchenne Muscular Dystrophy Sales by Region (2016-2021) & (K Doses) Table 38. APAC Duchenne Muscular Dystrophy Sales Market Share by Region (2016-2021) Table 39. APAC Duchenne Muscular Dystrophy Revenue by Region (2016-2021) & ($ Millions) Table 40. APAC Duchenne Muscular Dystrophy Revenue Market Share by Region (2016-2021) Table 41. APAC Duchenne Muscular Dystrophy Sales by Type (2016-2021) & (K Doses) Table 42. APAC Duchenne Muscular Dystrophy Sales Market Share by Type (2016-2021) Table 43. APAC Duchenne Muscular Dystrophy Sales by Application (2016-2021) & (K Doses) Table 44. APAC Duchenne Muscular Dystrophy Sales Market Share by Application (2016-2021) Table 45. Europe Duchenne Muscular Dystrophy Sales by Country (2016-2021) & (K Doses) Table 46. Europe Duchenne Muscular Dystrophy Sales Market Share by Country (2016-2021) Table 47. Europe Duchenne Muscular Dystrophy Revenue by Country (2016-2021) & ($ Millions) Table 48. Europe Duchenne Muscular Dystrophy Revenue Market Share by Country (2016-2021) Table 49. Europe Duchenne Muscular Dystrophy Sales by Type (2016-2021) & (K Doses) Table 50. Europe Duchenne Muscular Dystrophy Sales Market Share by Type (2016-2021) Table 51. Europe Duchenne Muscular Dystrophy Sales by Application (2016-2021) & (K Doses) Table 52. Europe Duchenne Muscular Dystrophy Sales Market Share by Application (2016-2021) Table 53. Middle East & Africa Duchenne Muscular Dystrophy Sales by Country (2016-2021) & (K Doses) Table 54. Middle East & Africa Duchenne Muscular Dystrophy Sales Market Share by Country (2016-2021) Table 55. Middle East & Africa Duchenne Muscular Dystrophy Revenue by Country (2016-2021) & ($ Millions) Table 56. Middle East & Africa Duchenne Muscular Dystrophy Revenue Market Share by Country (2016-2021) Table 57. Middle East & Africa Duchenne Muscular Dystrophy Sales by Type (2016-2021) & (K Doses) Table 58. Middle East & Africa Duchenne Muscular Dystrophy Sales Market Share by Type (2016-2021) Table 59. Middle East & Africa Duchenne Muscular Dystrophy Sales by Application (2016-2021) & (K Doses) Table 60. Middle East & Africa Duchenne Muscular Dystrophy Sales Market Share by Application (2016-2021) Table 61. Key and Potential Regions of Duchenne Muscular Dystrophy Table 62. Key Application and Potential Industries of Duchenne Muscular Dystrophy Table 63. Key Challenges of Duchenne Muscular Dystrophy Table 64. Key Trends of Duchenne Muscular Dystrophy Table 65. Duchenne Muscular Dystrophy Distributors List Table 66. Duchenne Muscular Dystrophy Customer List Table 67. Global Duchenne Muscular Dystrophy Sales Forecast by Region (2021-2026) & (K Doses) Table 68. Global Duchenne Muscular Dystrophy Consumption Market Forecast by Region Table 69. Global Duchenne Muscular Dystrophy Revenue Forecast by Region (2021-2026) & ($ millions) Table 70. Global Duchenne Muscular Dystrophy Revenue Market Share Forecast by Region (2021-2026) Table 71. Americas Duchenne Muscular Dystrophy Sales Forecast by Country (2021-2026) & (K Doses) Table 72. Americas Duchenne Muscular Dystrophy Revenue Forecast by Country (2021-2026) & ($ millions) Table 73. APAC Duchenne Muscular Dystrophy Sales Forecast by Region (2021-2026) & (K Doses) Table 74. APAC Duchenne Muscular Dystrophy Revenue Forecast by Region (2021-2026) & ($ millions) Table 75. Europe Duchenne Muscular Dystrophy Sales Forecast by Country (2021-2026) & (K Doses) Table 76. Europe Duchenne Muscular Dystrophy Revenue Forecast by Country (2021-2026) & ($ millions) Table 77. Middle East & Africa Duchenne Muscular Dystrophy Sales Forecast by Country (2021-2026) & (K Doses) Table 78. Middle East & Africa Duchenne Muscular Dystrophy Revenue Forecast by Country (2021-2026) & ($ millions) Table 79. Global Duchenne Muscular Dystrophy Sales Forecast by Type (2021-2026) & (K Doses) Table 80. Global Duchenne Muscular Dystrophy Sales Market Share Forecast by Type (2021-2026) Table 81. Global Duchenne Muscular Dystrophy Revenue Forecast by Type (2021-2026) & ($ Millions) Table 82. Global Duchenne Muscular Dystrophy Revenue Market Share Forecast by Type (2021-2026) Table 83. Global Duchenne Muscular Dystrophy Sales Forecast by Application (2021-2026) & (K Doses) Table 84. Global Duchenne Muscular Dystrophy Sales Market Share Forecast by Application (2021-2026) Table 85. Global Duchenne Muscular Dystrophy Revenue Forecast by Application (2021-2026) & ($ Millions) Table 86. Global Duchenne Muscular Dystrophy Revenue Market Share Forecast by Application (2021-2026) Table 87. Sarepta Therapeutics Basic Information, Duchenne Muscular Dystrophy Manufacturing Base, Sales Area and Its Competitors Table 88. Sarepta Therapeutics Duchenne Muscular Dystrophy Product Offered Table 89. Sarepta Therapeutics Duchenne Muscular Dystrophy Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 90. Sarepta Therapeutics Main Business Table 91. Sarepta Therapeutics Latest Developments Table 92. PTC Therapeutics Basic Information, Duchenne Muscular Dystrophy Manufacturing Base, Sales Area and Its Competitors Table 93. PTC Therapeutics Duchenne Muscular Dystrophy Product Offered Table 94. PTC Therapeutics Duchenne Muscular Dystrophy Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 95. PTC Therapeutics Main Business Table 96. PTC Therapeutics Latest Developments Table 97. Pfizer Basic Information, Duchenne Muscular Dystrophy Manufacturing Base, Sales Area and Its Competitors Table 98. Pfizer Duchenne Muscular Dystrophy Product Offered Table 99. Pfizer Duchenne Muscular Dystrophy Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 100. Pfizer Main Business Table 101. Pfizer Latest Developments Table 102. Bristol-Myers Squibb Basic Information, Duchenne Muscular Dystrophy Manufacturing Base, Sales Area and Its Competitors Table 103. Bristol-Myers Squibb Duchenne Muscular Dystrophy Product Offered Table 104. Bristol-Myers Squibb Duchenne Muscular Dystrophy Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 105. Bristol-Myers Squibb Main Business Table 106. Bristol-Myers Squibb Latest Developments Table 107. Italfarmaco Basic Information, Duchenne Muscular Dystrophy Manufacturing Base, Sales Area and Its Competitors Table 108. Italfarmaco Duchenne Muscular Dystrophy Product Offered Table 109. Italfarmaco Duchenne Muscular Dystrophy Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 110. Italfarmaco Main Business Table 111. Italfarmaco Latest Developments Table 112. Santhera Pharmaceuticals Basic Information, Duchenne Muscular Dystrophy Manufacturing Base, Sales Area and Its Competitors Table 113. Santhera Pharmaceuticals Duchenne Muscular Dystrophy Product Offered Table 114. Santhera Pharmaceuticals Duchenne Muscular Dystrophy Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 115. Santhera Pharmaceuticals Main Business Table 116. Santhera Pharmaceuticals Latest Developments List of Figures Figure 1. Picture of Duchenne Muscular Dystrophy Figure 2. Duchenne Muscular Dystrophy Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Duchenne Muscular Dystrophy Sales Growth Rate 2016-2026 (K Doses) Figure 7. Global Duchenne Muscular Dystrophy Revenue Growth Rate 2016-2026 ($ Millions) Figure 8. Duchenne Muscular Dystrophy Sales by Region (2021 & 2026) & ($ millions) Figure 9. Product Picture of Exondys 51 Figure 10. Product Picture of Emflaza Figure 11. Product Picture of Translarna Figure 12. Global Duchenne Muscular Dystrophy Sales Market Share by Type in 2020 Figure 13. Global Duchenne Muscular Dystrophy Revenue Market Share by Type (2016-2021) Figure 14. Duchenne Muscular Dystrophy Consumed in Hospitals Figure 15. Global Duchenne Muscular Dystrophy Market: Hospitals (2016-2021) & (K Doses) Figure 16. Duchenne Muscular Dystrophy Consumed in Clinics Figure 17. Global Duchenne Muscular Dystrophy Market: Clinics (2016-2021) & (K Doses) Figure 18. Duchenne Muscular Dystrophy Consumed in Home Care Figure 19. Global Duchenne Muscular Dystrophy Market: Home Care (2016-2021) & (K Doses) Figure 20. Global Duchenne Muscular Dystrophy Sales Market Share by Application (2016-2021) Figure 21. Global Duchenne Muscular Dystrophy Revenue Market Share by Application in 2020 Figure 22. Duchenne Muscular Dystrophy Revenue Market by Company in 2020 ($ Million) Figure 23. Global Duchenne Muscular Dystrophy Revenue Market Share by Company in 2020 Figure 24. Global Duchenne Muscular Dystrophy Sales Market Share by Regions (2016-2021) Figure 25. Global Duchenne Muscular Dystrophy Revenue Market Share by Region in 2020 Figure 26. Americas Duchenne Muscular Dystrophy Sales 2016-2021 (K Doses) Figure 27. Americas Duchenne Muscular Dystrophy Revenue 2016-2021 ($ Millions) Figure 28. APAC Duchenne Muscular Dystrophy Sales 2016-2021 (K Doses) Figure 29. APAC Duchenne Muscular Dystrophy Revenue 2016-2021 ($ Millions) Figure 30. Europe Duchenne Muscular Dystrophy Sales 2016-2021 (K Doses) Figure 31. Europe Duchenne Muscular Dystrophy Revenue 2016-2021 ($ Millions) Figure 32. Middle East & Africa Duchenne Muscular Dystrophy Sales 2016-2021 (K Doses) Figure 33. Middle East & Africa Duchenne Muscular Dystrophy Revenue 2016-2021 ($ Millions) Figure 34. Americas Duchenne Muscular Dystrophy Sales Market Share by Country in 2020 Figure 35. Americas Duchenne Muscular Dystrophy Revenue Market Share by Country in 2020 Figure 36. Americas Duchenne Muscular Dystrophy Sales Market Share by Type in 2020 Figure 37. Americas Duchenne Muscular Dystrophy Sales Market Share by Application in 2020 Figure 38. United States Duchenne Muscular Dystrophy Revenue Growth 2016-2021 ($ Millions) Figure 39. Canada Duchenne Muscular Dystrophy Revenue Growth 2016-2021 ($ Millions) Figure 40. Mexico Duchenne Muscular Dystrophy Revenue Growth 2016-2021 ($ Millions) Figure 41. Brazil Duchenne Muscular Dystrophy Revenue Growth 2016-2021 ($ Millions) Figure 42. APAC Duchenne Muscular Dystrophy Sales Market Share by Region in 2020 Figure 43. APAC Duchenne Muscular Dystrophy Revenue Market Share by Regions in 2020 Figure 44. APAC Duchenne Muscular Dystrophy Sales Market Share by Type in 2020 Figure 45. APAC Duchenne Muscular Dystrophy Sales Market Share by Application in 2020 Figure 46. China Duchenne Muscular Dystrophy Revenue Growth 2016-2021 ($ Millions) Figure 47. Japan Duchenne Muscular Dystrophy Revenue Growth 2016-2021 ($ Millions) Figure 48. Korea Duchenne Muscular Dystrophy Revenue Growth 2016-2021 ($ Millions) Figure 49. Southeast Asia Duchenne Muscular Dystrophy Revenue Growth 2016-2021 ($ Millions) Figure 50. India Duchenne Muscular Dystrophy Revenue Growth 2016-2021 ($ Millions) Figure 51. Australia Duchenne Muscular Dystrophy Revenue Growth 2016-2021 ($ Millions) Figure 52. Europe Duchenne Muscular Dystrophy Sales Market Share by Country in 2020 Figure 53. Europe Duchenne Muscular Dystrophy Revenue Market Share by Country in 2020 Figure 54. Europe Duchenne Muscular Dystrophy Sales Market Share by Type in 2020 Figure 55. Europe Duchenne Muscular Dystrophy Sales Market Share by Application in 2020 Figure 56. Germany Duchenne Muscular Dystrophy Revenue Growth 2016-2021 ($ Millions) Figure 57. France Duchenne Muscular Dystrophy Revenue Growth 2016-2021 ($ Millions) Figure 58. UK Duchenne Muscular Dystrophy Revenue Growth 2016-2021 ($ Millions) Figure 59. Italy Duchenne Muscular Dystrophy Revenue Growth 2016-2021 ($ Millions) Figure 60. Russia Duchenne Muscular Dystrophy Revenue Growth 2016-2021 ($ Millions) Figure 61. Middle East & Africa Duchenne Muscular Dystrophy Sales Market Share by Country in 2020 Figure 62. Middle East & Africa Duchenne Muscular Dystrophy Revenue Market Share by Country in 2020 Figure 63. Middle East & Africa Duchenne Muscular Dystrophy Sales Market Share by Type in 2020 Figure 64. Middle East & Africa Duchenne Muscular Dystrophy Sales Market Share by Application in 2020 Figure 65. Egypt Duchenne Muscular Dystrophy Revenue Growth 2016-2021 ($ Millions) Figure 66. South Africa Duchenne Muscular Dystrophy Revenue Growth 2016-2021 ($ Millions) Figure 67. Israel Duchenne Muscular Dystrophy Revenue Growth 2016-2021 ($ Millions) Figure 68. Turkey Duchenne Muscular Dystrophy Revenue Growth 2016-2021 ($ Millions) Figure 69. GCC Country Duchenne Muscular Dystrophy Revenue Growth 2016-2021 ($ Millions) Figure 70. Channels of Distribution Figure 71. Distributors Profiles